Skip to main content

Table 2 Clinical parameters of platelets from healthy donors and lung cancer patients

From: MicroRNA-223 delivered by platelet-derived microvesicles promotes lung cancer cell invasion via targeting tumor suppressor EPB41L3

  Sample number PLT (×10 9 /L) PCT (%) MPV (fl) PDW (%)
Healthy 20 212.53 ± 45.41 0.2095 ± 0.09 8.35 ± 1.35 14.9 ± 1.75
NSCLC 20 268.47 ± 73.62*** 0.2694 ± 0.04** 9.65 ± 1.9 16.4 ± 1.50
  1. PLT, platelets; PCT, Platelet hematocrit; MPV, Mean platelet volume; PDW, platelet distribution width; Statistical comparison was performed by using Student’s t-test (*, P < 0.05, **, P < 0.01, ***, P < 0.001).